 An overexpressed or a mutated transmembrane epidermal growth factor receptor (EGFR for details regarding this receptor family, see Hollmen and Elenius (1)) that modulates its physiological functions (cell growth, proliferation, migration, etc.) through an intracellular tyrosine kinase (TK) signaling pathway is known to be involved in the development of various cancers (2). As a consequence, one of the strategies used for the 